Clinical Trial Update: LONG-TERM EFFECTIVENESS AND SAFETY EVALUATION OF OCRELIZUMAB [Phase 3]

View source ↗

Summary

Phase 3 long-term evaluation of the effectiveness and safety of ocrelizumab for multiple sclerosis; the trial is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Ocrelizumab (ocrelizumab)

Snippet

Sponsor: Centre Hospitalier Universitaire de Nice | Conditions: Multiple Sclerosis | Phase 3 | Status: ACTIVE_NOT_RECRUITING